Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
National Health InvestorsNHI +1.33%79 EBITDA Margin % is 79.62% as of Jun. 2026, which is 8% below its 10-year median of 86.34. GuruFocus rates NHI with a GF Score™ of 79/100 and a GF Value™ of $85.01 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 731 REITs companies, National Health Investors ranks better than 54.17% on this metric.
National Health Investors (NYSE:NHI) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
National Health Investors EBITDA Margin % Related Terms
National Health Investors EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the REIT - Healthcare Facilities subindustry, National Health Investors's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
National Health Investors EBITDA Margin % vs REITs Industry
For the REITs industry and Real Estate sector, National Health Investors's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where National Health Investors's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
National Health Investors (NHI) has a EBITDA Margin % of 79.62% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on National Health Investors and its competitors. This is near median its historical median of 86.34. Over the past decade, National Health Investors' EBITDA Margin % has ranged from 64.25 to 103.09. According to the industry distribution chart, National Health Investors ranks #335 out of 731 companies in the REITs industry, placing it in the top 45.8%.
Is National Health Investors' EBITDA Margin % too high?
National Health Investors' current EBITDA Margin % of 79.62% is near median its 10-year median of 86.34. Over the past 10 years, this metric has ranged from a low of 64.25 to a high of 103.09. The REITs industry median EBITDA Margin % is 69.20. National Health Investors' value of 79.62% is 15.1% above this industry median. Based on the distribution chart, National Health Investors ranks #335 out of 731 companies in the REITs industry, which is above the industry midpoint. Overall, National Health Investors has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does National Health Investors' EBITDA Margin % compare to MPT and LTC?
According to the REITs industry distribution chart, National Health Investors ranks #335 out of 731 companies for EBITDA Margin %. This puts National Health Investors in the upper half of its industry. The industry median EBITDA Margin % is 69.20. National Health Investors' value of 79.62% is 15.1% above this benchmark. Historically, National Health Investors' own EBITDA Margin % has ranged from 64.25 to 103.09 over the past decade. While the company's 10-year median is 86.34 vs. the industry median of 69.20, National Health Investors has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a REITs company?
The median EBITDA Margin % among REITs companies is 69.20, based on 731 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. National Health Investors's current EBITDA Margin % of 79.62% is 15.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on National Health Investors and its competitors. For the REITs industry, the median EBITDA Margin % is 69.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. National Health Investors's current EBITDA Margin % is 79.62%, which is near median its own 10-year median of 86.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is National Health Investors stock overvalued right now?
Based on GuruFocus' analysis, National Health Investors (NHI) is currently considered Modestly Undervalued. The stock's GF Value™ is $85.01, compared to a current price of $72.06 — trading 15.2% below its estimated fair value. The current EBITDA Margin % is 79.62%, which is near median its 10-year median of 86.34 and 15.1% above the REITs industry median of 69.20. National Health Investors' overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For National Health Investors (NHI), the current EBITDA Margin % is 79.62% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is National Health Investors (NHI) Overvalued in 2026?
Based on GuruFocus' analysis, National Health Investors stock appears to be undervalued.
The current stock price of $72.06 is trading 15.2% below its estimated GF Value™ of $85.01.
GuruFocus considers National Health Investors to be Modestly Undervalued.
Key valuation signals for NHI:
EBITDA Margin %: 79.62% (near median its 10-year median of 86.34)
GF Value™: $85.01 vs. price of $72.06 (15.2% below fair value)
Industry Position: 15.1% above the REITs median (#335 of 731)
No single metric tells the full story. See the NHI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
National Health Investors Inc is a self-managed REIT that owns, leases, operates, and finances the development of senior housing communities and medical facilities. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates the majority of revenue, includes real estate leases, mortgages, and other notes receivable related to independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment consists of ventures that own and operate independent living facilities. The company's revenues are derived from rental income, interest and other income, and resident fees and services.
79GF Score
Get the complete analysis for NHI
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NHI has been successfully added to your 
